Skip to main content
. 2022 Sep 8;12:15058. doi: 10.1038/s41598-022-18324-3

Figure 4.

Figure 4

Propranolol treatment inhibits osteosarcoma-driven angiogenesis. Impact of propranolol (PPN) administration (10 mg/kg/day, i.p.) on MG-63-induced angiogenesis was assessed using a modified-Matrigel plug assay in nude mice. (a) Experimental design and PPN dosing. (b) Early angiogenic response was assessed by quantification of hemoglobin content in the recovered Matrigel plugs using the Drabkin’s method (see "Methods" section). (c) Representative photographs of subcutaneous vascularized implants in vehicle or PPN-treated animals. Five animals per experimental group. Data are presented as mean ± SEM. *p < 0.05, unpaired t test.